MDXHF (Medx Health) Gross Margin %: 34.62% (As of Mar. 2026) — 30% Below Median


What is Medx Health Gross Margin %?

Medx Health MDXHF Gross Margin % is 34.62% as of Mar. 2026, which is 30% below its 10-year median of 49.53. The stock has 8 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Medx Health ranks worse than 81.37% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Medx Health's Gross Profit for the three months ended in Mar. 2026 was $0.05 Mil. Medx Health's Revenue for the three months ended in Mar. 2026 was $0.13 Mil. Therefore, Medx Health's Gross Margin % for the quarter that ended in Mar. 2026 was 34.62%.

Warning Sign:

Medx Health Corp gross margin has been in long-term decline. The average rate of decline per year is -8.6%.


The historical rank and industry rank for Medx Health's Gross Margin % or its related term are showing as below:

MDXHF' s Gross Margin % Range Over the Past 10 Years
Min: 30   Med: 49.53   Max: 63.39
Current: 30


During the past 13 years, the highest Gross Margin % of Medx Health was 63.39%. The lowest was 30.00%. And the median was 49.53%.

MDXHF's Gross Margin % is ranked worse than
81.37% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 52.03 vs MDXHF: 30.00

Medx Health had a gross margin of 34.62% for the quarter that ended in Mar. 2026 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Medx Health was -8.60% per year.


Medx Health  (OTCPK:MDXHF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Medx Health had a gross margin of 34.62% for the quarter that ended in Mar. 2026 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Medx Health Gross Margin % Related Terms


Medx Health Gross Margin % Historical Data

* Premium members only.

The historical data trend for Medx Health's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medx Health Gross Margin % Chart

Medx Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.41 47.07 40.88 39.53 31.20

Medx Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.86 20.00 27.55 33.00 34.62

MDXHF vs ABT, SYK, MDT: Gross Margin % Comparison

For the Medical Devices subindustry, Medx Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medx Health Gross Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medx Health's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Medx Health's Gross Margin % falls into.



Medx Health Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Medx Health's Gross Margin for the fiscal year that ended in Dec. 2025 is calculated as

Gross Margin % (A: Dec. 2025 )=Gross Profit (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=0.1 / 0.343
=(Revenue - Cost of Goods Sold) / Revenue
=(0.343 - 0.236) / 0.343
=31.20 %

Medx Health's Gross Margin for the quarter that ended in Mar. 2026 is calculated as


Gross Margin % (Q: Mar. 2026 )=Gross Profit (Q: Mar. 2026 ) / Revenue (Q: Mar. 2026 )
=0 / 0.13
=(Revenue - Cost of Goods Sold) / Revenue
=(0.13 - 0.085) / 0.13
=34.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 34.62% mean?
Medx Health (MDXHF) has a Gross Margin % of 34.62% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Medx Health and its competitors. This is 30% below median its historical median of 49.53. Over the past decade, Medx Health's Gross Margin % has ranged from 30.00 to 63.39. According to the industry distribution chart, Medx Health ranks #655 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 81.4%.
Is Medx Health's Gross Margin % too high?
Medx Health's current Gross Margin % of 34.62% is 30% below median its 10-year median of 49.53. Over the past 10 years, this metric has ranged from a low of 30.00 to a high of 63.39. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Medx Health's value of 34.62% is 33.5% below this industry median. Based on the distribution chart, Medx Health ranks #655 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Medx Health's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medx Health ranks #655 out of 805 companies for Gross Margin %. This places Medx Health in the lower half of its industry. The industry median Gross Margin % is 52.03. Medx Health's value of 34.62% is 33.5% below this benchmark. Historically, Medx Health's own Gross Margin % has ranged from 30.00 to 63.39 over the past decade. While the company's 10-year median is 49.53 vs. the industry median of 52.03, Medx Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medx Health's current Gross Margin % of 34.62% is 33.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Medx Health and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medx Health's current Gross Margin % is 34.62%, which is 30% below median its own 10-year median of 49.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medx Health stock overvalued right now?
Based on GuruFocus' analysis, Medx Health (MDXHF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 20% above its estimated fair value. The current Gross Margin % is 34.62%, which is 30% below median its 10-year median of 49.53 and 33.5% below the Medical Devices & Instruments industry median of 52.03. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Medx Health (MDXHF), the current Gross Margin % is 34.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medx Health Business Description

Other Exchanges MDX:Canada
Address 1495 Bonhill Road, Unit 1, Mississauga, ON, CAN, L5T 1M2
Medx Health Corp is engaged in the development, manufacturing, and marketing skin-related screening tools and phototherapy devices for pain relief and tissue repair, marketing the latter in Canada and the United States while the skin related screening tools are also marketed in Europe, Australia and selected markets in Latin America. It offers DermSecure, and MedX Laser Therapy.